The study that 'should basically end any scientific debate' about masks

A massive randomized trial on how well masks hold up against symptomatic COVID-19 infections may be one of the most crucial studies of the coronavirus pandemic because it was able to solve the tricky issue of examining mask-wearing at a community level rather than an individual one.
The study involved launching pro-mask campaigns in some Bangladeshi villages, but not others, and the authors made two key findings. First, they determined that the public health interventions nearly tripled mask usage from 13 percent to 42 percent. Secondly, they discovered — by conducting sero-surveys backed up by interviews about COVID-19 symptoms and medical history — that masks did their job and reduced symptomatic infections in the communities that were subject to the campaigns by 9.3 percent. Jason Abaluck, an economist at Yale University who helped lead the study, told The Washington Post that figure would probably be higher if masking was universal.
There were a few other key notes in the study. Surgical masks were found to be particularly effective, while the jury is still out on cloth masks. And they were more effective in people older than 50, which could be explained by a few factors, including that young people were less likely to be symptomatic either way. They also may have been less compliant when it comes to masks.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Either way, Abaluck is pretty confident about the research, arguing that it "should basically end any scientific debate about whether masks can be effective in combating [COVID-19] at the population level" and calling it "a nail in the coffin" for anti-mask arguments. Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
By Peter Weber, The Week US
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US